Newcleo H1 operating loss widens to EUR 81.12 million; revenue rises 46% to EUR 19.43 million

• Newcleo posted a net loss of EUR 81.98 million for the six months ended June 30, 2026, widening from EUR 74.29 million.
• Revenue rose 46% to EUR 19.43 million, while operating loss widened to EUR 81.12 million.
• Selling, general and administrative expenses climbed 21% to EUR 59.17 million, while research and development expenses fell to EUR 34.63 million.
• Cash and cash equivalents fell to EUR 66.54 million at June 30, 2026, while net cash used in operating activities totaled EUR 53.69 million.
• Management said SG&A increased mainly on share-based payment expense and transaction costs tied to the business combination with NewHold.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Newcleo plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-038557), on October 05, 2026, and is solely responsible for the information contained therein.